Star Polypeptides with Controlled NCA Polymerization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current star polypeptides lack precise structural control, which hinders their therapeutic loading and transfection properties, and existing methods for preparing hyperbranched polylysine structures do not allow for optimal control over molecular weight and branching points.
Innovation Solution
Development of star polypeptides with a core and radiating polypeptide arms, which can stimulate cell growth, tissue regeneration, and exhibit anti-bacterial properties without the need for additional therapeutic agents, and can also deliver therapeutic cargo such as nucleic acids or proteins, utilizing specific arm lengths and compositions to enhance bioactivity and delivery efficiency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If existing methods for preparing hyperbranched polylys structures are used, then production is achieved, but precise structural control (molecular weight, branching points) is lost
Solution Approach 1:
The patent segments the polymerization process into controlled stages using N-carboxyanhydride (NCA) monomers that polymerize in a stepwise manner. Each NCA unit adds a defined amino acid residue to the growing chain, enabling precise control over molecular weight and branching architecture while maintaining ease of manufacture through modular synthesis
Solution Approach 2:
The patent employs parameter changes by controlling the NCA polymerization conditions (monomer selection, catalysts, temperature, solvent) to precisely tune the molecular weight, polydispersity index, and branching structure of the resulting polypeptides, achieving high manufacturing precision without excessive complexity
2Reliability
If star polypeptides are designed with specific arm lengths and compositions, then bioactivity and delivery efficiency are enhanced, but structural control difficulty increases
Solution Approach 1:
The star polypeptide is segmented into a core structure and multiple radiating arms, where each arm can be independently designed with specific amino acid compositions and lengths. This segmentation allows precise control over bioactivity through arm design while simplifying structural control by using modular NCA building blocks
Solution Approach 2:
Different arms of the star polypeptide can have different local qualities (amino acid compositions, lengths, charges) to perform specific functions such as cargo binding, cellular targeting, or stability enhancement, while the overall structure maintains controlled architecture through the standardized NCA polymerization approach
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The star polypeptides demonstrate intrinsic bioactivity for osteogenic, angiogenic, and anti-bacterial effects, and can effectively deliver therapeutic cargo, offering improved tissue regeneration, bacterial inhibition, and gene delivery capabilities with controlled release and targeted delivery options.
Implementation Method 1
Following addition of a nucleophile the NCA ring structure undergoes a ring opening polymerisation (ROP) reaction which allows for the synthesis of polypeptides
Data Source
AI summary
A star polypeptide for use as a medicament, the star polypeptide comprising or consisting of a core and polypeptide arms radiating from the core. The star polypeptide may be used to deliver a therapeutic cargo and/or for its intrinsic properties. Therapeutic cargoes include a protein(e.g. VEGF); a nucleic acid (e.g. in vitro transcribed mRNA or microRNA); and/or a drug (e.g. diclofenac, azithromycin and/or rifampicin). Intrinsic properties include osteogenesis, angiogenesis and inhibition of bacteria.